Skip to content

Skin Microbiome of Chinese Population Cohort Study

Skin Microbiome of Chinese Population Cohort Study: Association Between Human Health and Skin Microbiome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05804851
Enrollment
237
Registered
2023-04-07
Start date
2023-05-08
Completion date
2025-12-31
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Microbiome

Brief summary

This observational study aims to investigate the relationship between public health and the skin microbiome in the province of Zhejiang. Due to the lack of current research on the skin microbiome, the following general questions will be investigated in this study: 1) What connection exists between dietary practices and facial skin microbiome? 2) How do people's lifestyle routines affect the facial skin microbiome? 3) What effects does the altered living environment have on people's facial skin microbiomes? 4) How do the seasons affect people's facial skin microbiomes? Every 3 to 4 months, the participants' facial skin microbiota samples will be taken, and they will be asked to complete a survey.

Interventions

None listed

Sponsors

Westlake University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
10 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* ages from 10+.

Exclusion criteria

* a severe medical history, including a history of surgery or medication, or serious illnesses such as cancer, liver disease, kidney disease, or craniocerebral trauma. * recent medical treatment (topical antibiotics, corticosteroids, and other anti-inflammatory drugs within 4 weeks, and systemic antibiotics, corticosteroids, and other immunosuppressive drugs within 6 months)

Design outcomes

Primary

MeasureTime frameDescription
Changes in facial microbiota profilingDay 1, Day 90, Day 180, Day 270, and Day 360Quantitative and qualitative analysis of bacteria population from the sample, rRNA and metagenome sequencing will be conducted on each sample

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026